Clinical Characteristics of Post-COVID-19 Persistent Cough in the Omicron Era.

IF 4.1 2区 医学 Q2 ALLERGY Allergy, Asthma & Immunology Research Pub Date : 2023-05-01 DOI:10.4168/aair.2023.15.3.395
Yu Ri Kang, Jin-Young Huh, Ji-Yoon Oh, Ji-Hyang Lee, Daegeun Lee, Hyouk-Soo Kwon, Tae-Bum Kim, Jae Chol Choi, You Sook Cho, Kian Fan Chung, So-Young Park, Woo-Jung Song
{"title":"Clinical Characteristics of Post-COVID-19 Persistent Cough in the Omicron Era.","authors":"Yu Ri Kang,&nbsp;Jin-Young Huh,&nbsp;Ji-Yoon Oh,&nbsp;Ji-Hyang Lee,&nbsp;Daegeun Lee,&nbsp;Hyouk-Soo Kwon,&nbsp;Tae-Bum Kim,&nbsp;Jae Chol Choi,&nbsp;You Sook Cho,&nbsp;Kian Fan Chung,&nbsp;So-Young Park,&nbsp;Woo-Jung Song","doi":"10.4168/aair.2023.15.3.395","DOIUrl":null,"url":null,"abstract":"<p><p>Cough is one of the most common symptoms of acute coronavirus disease 2019, but cough may persist for weeks or months. This study aimed to examine the clinical characteristics of patients with post-coronavirus disease (COVID) persistent cough in the Omicron era. We conducted a pooled analysis comparing 3 different groups: 1) a prospective cohort of post-COVID cough (> 3 weeks; n = 55), 2) a retrospective cohort of post-COVID cough (> 3 weeks; n = 66), and 3) a prospective cohort of non-COVID chronic cough (CC) (> 8 weeks; n = 100). Cough and health status was assessed using patient-reported outcomes (PROs). Outcomes, including PROs and systemic symptoms, were longitudinally evaluated in the prospective post-COVID cough registry participants receiving usual care. A total of 121 patients with post-COVID cough and 100 with non-COVID CC were studied. Baseline cough-specific PRO scores did not significantly differ between post-COVID cough and non-COVID CC groups. There were no significant differences in chest imaging abnormality or lung function between groups. However, the proportions of patients with fractional exhaled nitric oxide (FeNO) ≥ 25 ppb were 44.7% in those with post-COVID cough and 22.7% in those with non-COVID CC, which were significantly different. In longitudinal assessment of the post-COVID registry (n = 43), cough-specific PROs, such as cough severity or Leicester Cough Questionnaire (LCQ) scores, significantly improved between visits 1 and 2 (visit interval: median 35 [interquartile range, IQR: 23-58] days). In the LCQ score, 83.3% of the patients showed improvement (change ≥ +1.3), but 7.1% had worsened (≤ -1.3). The number of systemic symptoms was median 4 (IQR: 2-7) at visit 1 but decreased to median 2 (IQR: 0-4) at visit 2. In summary, post-COVID persistent cough was similar in overall clinical characteristics to CC. Current cough guideline-based approaches may be effective in most patients with post-COVID cough. Measurement of FeNO levels may also be useful for cough management.</p>","PeriodicalId":7547,"journal":{"name":"Allergy, Asthma & Immunology Research","volume":"15 3","pages":"395-405"},"PeriodicalIF":4.1000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/8f/aair-15-395.PMC10186121.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy, Asthma & Immunology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4168/aair.2023.15.3.395","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Cough is one of the most common symptoms of acute coronavirus disease 2019, but cough may persist for weeks or months. This study aimed to examine the clinical characteristics of patients with post-coronavirus disease (COVID) persistent cough in the Omicron era. We conducted a pooled analysis comparing 3 different groups: 1) a prospective cohort of post-COVID cough (> 3 weeks; n = 55), 2) a retrospective cohort of post-COVID cough (> 3 weeks; n = 66), and 3) a prospective cohort of non-COVID chronic cough (CC) (> 8 weeks; n = 100). Cough and health status was assessed using patient-reported outcomes (PROs). Outcomes, including PROs and systemic symptoms, were longitudinally evaluated in the prospective post-COVID cough registry participants receiving usual care. A total of 121 patients with post-COVID cough and 100 with non-COVID CC were studied. Baseline cough-specific PRO scores did not significantly differ between post-COVID cough and non-COVID CC groups. There were no significant differences in chest imaging abnormality or lung function between groups. However, the proportions of patients with fractional exhaled nitric oxide (FeNO) ≥ 25 ppb were 44.7% in those with post-COVID cough and 22.7% in those with non-COVID CC, which were significantly different. In longitudinal assessment of the post-COVID registry (n = 43), cough-specific PROs, such as cough severity or Leicester Cough Questionnaire (LCQ) scores, significantly improved between visits 1 and 2 (visit interval: median 35 [interquartile range, IQR: 23-58] days). In the LCQ score, 83.3% of the patients showed improvement (change ≥ +1.3), but 7.1% had worsened (≤ -1.3). The number of systemic symptoms was median 4 (IQR: 2-7) at visit 1 but decreased to median 2 (IQR: 0-4) at visit 2. In summary, post-COVID persistent cough was similar in overall clinical characteristics to CC. Current cough guideline-based approaches may be effective in most patients with post-COVID cough. Measurement of FeNO levels may also be useful for cough management.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
欧米克隆时代新冠肺炎后持续咳嗽的临床特征
咳嗽是2019年急性冠状病毒病最常见的症状之一,但咳嗽可能持续数周或数月。本研究旨在探讨欧米克隆时代后冠状病毒病(COVID)持续咳嗽患者的临床特征。我们对3个不同组进行了汇总分析:1)新冠肺炎后咳嗽的前瞻性队列(> 3周;n = 55), 2)肺炎后咳嗽的回顾性队列(> 3周;n = 66), 3)非covid - 19慢性咳嗽(CC)前瞻性队列(> 8周;N = 100)。使用患者报告的结局(PROs)评估咳嗽和健康状况。在接受常规护理的前瞻性covid后咳嗽登记参与者中,对结果(包括PROs和全身性症状)进行了纵向评估。共研究121例新冠肺炎后咳嗽患者和100例非新冠肺炎CC患者。基线咳嗽特异性PRO评分在covid后咳嗽组和非covid CC组之间无显著差异。两组间胸部影像学异常及肺功能无明显差异。然而,分数次呼出一氧化氮(FeNO)≥25 ppb的患者比例在covid后咳嗽患者中为44.7%,在非covid CC患者中为22.7%,差异有统计学意义。在对covid后注册表(n = 43)的纵向评估中,咳嗽特异性PROs,如咳嗽严重程度或莱斯特咳嗽问卷(Leicester cough Questionnaire, LCQ)得分,在第1次和第2次就诊期间显著改善(就诊间隔:中位数35[四分位数间距,IQR: 23-58]天)。在LCQ评分中,83.3%的患者出现改善(变化≥+1.3),7.1%的患者出现恶化(≤-1.3)。在第一次就诊时,全身性症状的中位数为4 (IQR: 2-7),但在第二次就诊时降至中位数2 (IQR: 0-4)。综上所述,covid - 19后持续咳嗽的总体临床特征与CC相似,目前基于咳嗽指南的方法可能对大多数covid - 19后咳嗽患者有效。测量FeNO水平也可能对咳嗽管理有用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.10
自引率
6.80%
发文量
53
审稿时长
>12 weeks
期刊介绍: The journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.
期刊最新文献
Involvement of the Constitutive Photomorphogenesis 9 Signalosome Subunit 5 With Programmed Cell Death Protein 1 Ligand in Asthma. Neutrophil Extracellular Traps as a Biomarker in Refractory Non-Type 2 CRSwNP. Oral Administration of Lactococcus lactis Expressing Mite and Cockroach Major Allergens Alleviates Progression of Atopic March in a Mouse Model. Skin Lipid Barrier: Structure, Function and Metabolism. Treatment With Upadacitinib in Refractory Prurigo Nodularis: A Prospective Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1